AIHC Capital Management Ltd Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0002103725
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 4 positions · Total reported value $104.24M · Top-10 concentration 100.0% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 40.0% · 0 new · 1 cut · 1 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2026 13F filing, AIHC Capital Management Ltd disclosed 4 equity positions with a combined reported value of $104.24M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were RVMD ($56.77M), ORIC ($41.46M), NBP ($5.61M). By sector, the heaviest allocations are Health Care 100.0%.
Versus the prior quarter, AIHC Capital Management Ltd opened 0 new positions, trimmed 1 and fully exited 1, a turnover rate of 40.0% of positions. The portfolio's overlap with the prior quarter was 80% of names.
Of the 1 positions fully exited versus the prior quarter, the largest were COGT ($1.98M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
No new positions this quarter.
Fully Exited (vs previous quarter)
- COGT COGENT BIOSCIENCES INC · prev qtr: $1.98M
Insider Transactions (Form 4)
Latest AIHC Capital Management Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
AIHC Capital Management Ltd is an SEC-registered 13F filer. As of Q2 2026 it reported 4 US equity positions with a combined value of $104.24M. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).
Portfolio Structure
- 4 positions · $104.24M reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: RVMD (REVOLUTION MEDICINES INC) at 54.5%
- Average position size: $26.06M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 2 added, 1 reduced, 1 exited
- 1 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
Sector Allocation
FAQ
What did AIHC Capital Management Ltd buy in 2026-Q2?
In its 2026-Q2 13F filing, AIHC Capital Management Ltd reported 4 equity positions worth $104.24M in aggregate; its largest disclosed positions were RVMD ($56.77M), ORIC ($41.46M), NBP ($5.61M).
How large is AIHC Capital Management Ltd's portfolio?
AIHC Capital Management Ltd reported $104.24M of long equity holdings across 4 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.
What is AIHC Capital Management Ltd's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.